Search Results

There are 6315 results for: content related to: Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple Sclerosis

  1. You have free access to this content
    Estrogen receptor α induction by mitoxantrone increases Abcg2 expression in placental trophoblast cells

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3364–3372, Kenji Oda, Tomohiro Nishimura, Kei Higuchi, Naomi Ishido, Kaori Ochi, Hisashi Iizasa, Yoshimichi Sai, Masatoshi Tomi and Emi Nakashima

    Version of Record online : 16 APR 2013, DOI: 10.1002/jps.23549

  2. Spectral studies on the molecular interaction of anticancer drug mitoxantrone with CTAB micelles

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 558–565, Mirela Enache and Elena Volanschi

    Version of Record online : 28 JUL 2010, DOI: 10.1002/jps.22289

  3. You have free access to this content
    Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein

    International Journal of Cancer

    Volume 71, Issue 5, 29 May 1997, Pages: 817–824, Udo Kellner, Lesley Hutchinson, André Seidel, Hermann Lage, Mary K. Danks, Manfred Dietel and Scott H. Kaufmann

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19970529)71:5<817::AID-IJC20>3.0.CO;2-3

  4. Spectroscopic investigations of the molecular interaction of anticancer drug mitoxantrone with non-ionic surfactant micelles

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 5, May 2012, Pages: 688–696, Mirela Enache and Elena Volanschi

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.2042-7158.2012.01445.x

  5. You have free access to this content
    Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 152, Issue 1, January 2011, Pages: 61–71, Sarah L. Elliott, Clark Crawford, Evan Mulligan, Geoffrey Summerfield, Paula Newton, Jonathan Wallis, Tryfonia Mainou-Fowler, Paul Evans, Clare Bedwell, Barbara W. Durkacz and Elaine Willmore

    Version of Record online : 18 NOV 2010, DOI: 10.1111/j.1365-2141.2010.08425.x

  6. You have full text access to this Open Access content
    Evaluation of Single-Agent Mitoxantrone as Chemotherapy for Relapsing Canine Lymphoma

    Journal of Veterinary Internal Medicine

    Volume 12, Issue 5, September 1998, Pages: 325–329, Michael D. Lucroy, Brenda S. Phillips, Susan A. Kraegel, Eric R. Simonson and Bruce R. Madewell

    Version of Record online : 5 FEB 2008, DOI: 10.1111/j.1939-1676.1998.tb02130.x

  7. You have free access to this content
    Flow cytometric analysis of breast cancer resistance protein expression and function

    Cytometry

    Volume 48, Issue 2, 1 June 2002, Pages: 59–65, Hans Minderman, Attaya Suvannasankha, Kieran L. O'Loughlin, George L. Scheffer, Rik J. Scheper, Robert W. Robey and Maria R. Baer

    Version of Record online : 20 MAY 2002, DOI: 10.1002/cyto.10111

  8. Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteome

    PROTEOMICS - Clinical Applications

    Volume 3, Issue 3, No. 3 March 2009, Pages: 347–358, Juliane Symes, Andreas Evangelou, Alex Ignatchenko, Neil Fleshner, Thomas Kislinger and Jeffrey A. Medin

    Version of Record online : 27 FEB 2009, DOI: 10.1002/prca.200800102

  9. Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models

    The Prostate

    Volume 59, Issue 1, 1 April 2004, Pages: 22–32, Emily S. Van Laar, Steven Weitman, John R. MacDonald and Stephen J. Waters

    Version of Record online : 4 DEC 2003, DOI: 10.1002/pros.10351

  10. High-dose mitoxantrone in acute leukaemia: New York Medical College experience

    European Journal of Cancer Care

    Volume 6, Issue s1, June 1997, Pages: 27–32, ERIC J. FELDMAN

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1365-2354.1997.tb00322.x

  11. Mitoxantrone treatment of murine myeloid leukaemia sublines

    International Journal of Cancer

    Volume 60, Issue 2, 17 January 1995, Pages: 211–215, Aminu A. Abubakar and Andrew C. Riches

    Version of Record online : 18 JUL 2006, DOI: 10.1002/ijc.2910600214

  12. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma

    Veterinary and Comparative Oncology

    Volume 8, Issue 1, March 2010, Pages: 11–22, A. T. Daters, G. E. Mauldin, G. N. Mauldin, E. M. Brodsky and G. S. Post

    Version of Record online : 30 DEC 2009, DOI: 10.1111/j.1476-5829.2009.00199.x

  13. DNA strand breakage by peroxidase-activated mitoxantrone

    Journal of Pharmacy and Pharmacology

    Volume 43, Issue 1, January 1991, Pages: 65–68, GEOFFREY R. FISHER and LAURENCE H. PATTERSON

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1991.tb05455.x

  14. You have free access to this content
    Pharmacokinetic and pharmacodynamic studies with mitoxantrone in the treatment of patients with nasopharyngeal carcinoma

    Cancer

    Volume 69, Issue 4, 15 February 1992, Pages: 847–853, Oliver Yoa-Pu Hu, Shiu-Pei Chang, Chi-Kong Law, Jer-Min Jian and Kuang-Yao Chen

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19920215)69:4<847::AID-CNCR2820690402>3.0.CO;2-L

  15. You have free access to this content
    Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia

    Cancer

    Volume 65, Issue 12, 15 June 1990, Pages: 2619–2623, Lynne S. Kaminer, Kyung E. Choi, Karen M. Daley and Richard A. Larson

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19900615)65:12<2619::AID-CNCR2820651203>3.0.CO;2-I

  16. You have full text access to this Open Access content
    Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 1, January/February 2015, Pages: 261–267, S.D. Allstadt, C.O. Rodriguez Jr, B. Boostrom, R.B. Rebhun and K.A. Skorupski

    Version of Record online : 25 JAN 2015, DOI: 10.1111/jvim.12533

  17. Influence of mitoxantrone on nucleic acid synthesis on the T-47D breast tumor cell line

    Journal of Cellular Biochemistry

    Volume 22, Issue 2, 1983, Pages: 111–120, Ahmad R. Safa, Nasser Chegini and Michael T. Tseng

    Version of Record online : 19 FEB 2004, DOI: 10.1002/jcb.240220205

  18. You have free access to this content
    Mitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemia

    Cancer

    Volume 76, Issue 2, 15 July 1995, Pages: 339–342, Henk Behrendt, Catharina G. Massar and Eleonore F. van Leeuwen

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19950715)76:2<339::AID-CNCR2820760227>3.0.CO;2-Y

  19. High-dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease

    European Journal of Haematology

    Volume 48, Issue 2, February 1992, Pages: 110–114, S.H. Lim, T.P. Baglin, D. J. Flavell, S. U. Flavell, J. Z. Wimperis and R. E. Marcus

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1992.tb00575.x

  20. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia

    British Journal of Haematology

    Volume 170, Issue 5, September 2015, Pages: 704–718, Xin Long, Yang Yu, Laszlo Perlaky, Tsz-Kwong Man and Michele S. Redell

    Version of Record online : 14 MAY 2015, DOI: 10.1111/bjh.13492